Kyverna Therapeutics
Nasdaq KYTX · Emeryville, CA
Works in Dermatology · Immunology · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Women's health
Kyverna Therapeutics is a clinical trial sponsor based in Emeryville, CA, listed as Nasdaq KYTX. It has 3 active clinical trials with 256 planned participants, across 7 therapeutic areas. Since 2021 it has completed 1 trial and stopped 3 early.
Trial track record · since 2021
Financials · Nasdaq KYTX
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Kyverna Therapeutics
Kyverna Therapeutics is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 256 planned participants, in Dermatology, Immunology, Musculoskeletal, Neurology and other areas. Since 2021 it has completed 1 trial and stopped 3 early.
Kyverna Therapeutics is based in Emeryville, CA and is listed as Nasdaq KYTX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Kyverna Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-31.
Approve Suite is not affiliated with Kyverna Therapeutics.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.